SEBASTIEN GIBOT;INSERM (INSTITUT NATIONAL DE LA SANTE ET LA RECHE;AMIR BOUFENZER;HAFID AIT-OUFELLA;INSERM (Institut National de la Sante et de la Recherche Medicale);UNIVERSITE DE LORRAINE;MARC DERIVE
The present invention relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 2 and a function-conservative variant. The invention also relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 1 or SEQ ID NO: 2 and a function-conservative variant for use in the treatment of a cardiovascular disease.
